Corepharma Counterclaim Restored To Carbatrol Suit
A federal judge has allowed Corepharma LLC to seek a declaratory judgment that its application to make a generic version of the anti-seizure drug Carbatrol does not infringe Shire Laboratories Inc.'s...To view the full article, register now.
Already a subscriber? Click here to view full article